Abstract

Nursing home residents are at risk for becoming infected with and experiencing severe complications from respiratory viruses, including SARS-CoV-2, influenza, and respiratory syncytial virus (RSV). Fall 2023 is the first season during which vaccines are simultaneously available to protect older adults in the United States against all three of these respiratory viruses. Nursing homes are required to report COVID-19 vaccination coverage and can voluntarily report influenza and RSV vaccination coverage among residents to CDC's National Healthcare Safety Network. The purpose of this study was to assess COVID-19, influenza, and RSV vaccination coverage among nursing home residents during the current 2023-24 respiratory virus season. As of December 10, 2023, 33.1% of nursing home residents were up to date with vaccination against COVID-19. Among residents at 20.2% and 19.4% of facilities that elected to report, coverage with influenza and RSV vaccines was 72.0% and 9.8%, respectively. Vaccination varied by U.S. Department of Health and Human Services region, social vulnerability index level, and facility size. There is an urgent need to protect nursing home residents against severe outcomes of respiratory illnesses by continuing efforts to increase vaccination against COVID-19 and influenza and discussing vaccination against RSV with eligible residents during the ongoing 2023-24 respiratory virus season.

MeSH

Respiratory Syncytial Viruses, Mortality, Safety, Vaccines, Covid-19 Vaccines, Nursing, Home Nursing, Vaccination, Nursing Homes, Covid-19, Influenza, Human, Viruses, Morbidity, Vaccination Coverage, Nursing Home Residents

Cited by

• Measures to Prevent and Control COVID-19 in Skilled Nursing Facilities: A Scoping Review. JAMA Health Forum, 2025
• Leadership Perspectives on Nursing Home Operations From Crisis to Control: A Mixed Methods Study. J Am Med Dir Assoc, 2024
• Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents - National Healthcare Safety Network, United States, November 2024. MMWR Morb Mortal Wkly Rep, 2024
• Assessing the determinants of influenza and COVID-19 vaccine co-administration decisions in the elderly. Hum Vaccin Immunother, 2024
• Pneumococcal vaccination coverage: Residential Care Unit of the Community of Madrid. Rev Esp Quimioter, 2025
• Burden of Respiratory Syncytial Virus-Associated Hospitalizations in US Adults, October 2016 to September 2023. JAMA Netw Open, 2024
• Developing education to confront challenges with dyadic communication while wearing facemasks in long-term care. Geriatr Nurs, 2025
• Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysis. EClinicalMedicine, 2025